Swiss Reject Roche Holding AG's Tarceva for Pancreatic Cancer
Published: Mar 29, 2007
ZURICH, March 29 (Reuters) - Swiss health authorities have rejected drugmaker Roche Holding AG's Tarceva for use in pancreatic cancer, the company said on Thursday.
